Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Non-Current Debt (2012 - 2019)

Siga Technologies' (SIGA) quarterly Non-Current Debt came in at $78.9 million in Q3 2019, up 6.04% on a YoY basis from $74.4 million in Q3 2018, and up 1.46% quarter-over-quarter from $77.8 million in Q2 2019.

Analysis

Siga Technologies (SIGA) Non-Current Debt (2012 - 2019) Analysis & Trends

Siga Technologies (SIGA) has reported Non-Current Debt for 7 consecutive years, with $78.9 million the latest figure, recorded in Q3 2019.

  • For the quarter ending Q3 2019, Non-Current Debt rose 6.04% year-over-year to $78.9 million; the trailing twelve-month figure through Sep 2019 stood at $78.9 million (up 6.04% YoY), and the FY2018 full-year result was $75.5 million, up 6.33% from the prior year.
  • Non-Current Debt improved to $78.9 million in Q3 2019 per SIGA's latest filing, from $77.8 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $78.9 million in Q3 2019 and bottomed at $66.6 million in Q4 2016.
  • Historically, Non-Current Debt has averaged $72.7 million across 4 years, with a median of $72.7 million in 2018.
  • The sharpest annual moves came in 2017 and 2019: Non-Current Debt increased 6.76% in 2017, then climbed 6.04% in 2019.
  • Over 4 years, Non-Current Debt stood at $66.6 million in 2016, then advanced by 6.76% to $71.1 million in 2017, then gained by 6.33% to $75.5 million in 2018, then gained by 4.45% to $78.9 million in 2019.
  • According to Business Quant data, Non-Current Debt over the past three periods registered $78.9 million, $77.8 million, and $76.7 million for Q3 2019, Q2 2019, and Q1 2019 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 37.34 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 62.48 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 60.50 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 17.02 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn -
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn -
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 78.91 Mn
Jun 30, 2019 77.78 Mn
Mar 31, 2019 76.66 Mn
Dec 31, 2018 75.55 Mn
Sep 30, 2018 74.41 Mn
Jun 30, 2018 73.28 Mn
Mar 31, 2018 72.16 Mn
Dec 31, 2017 71.05 Mn
Sep 30, 2017 69.92 Mn
Jun 30, 2017 68.78 Mn
Mar 31, 2017 67.66 Mn
Dec 31, 2016 66.55 Mn
Dec 31, 2014 1.99 Mn
Sep 30, 2014 2.50 Mn
Jun 30, 2014 997,693.00
Mar 31, 2014 1.49 Mn
Dec 31, 2013 1.99 Mn
Sep 30, 2013 2.48 Mn
Jun 30, 2013 2.98 Mn
Mar 31, 2013 3.47 Mn